Johnson & Johnson concentrates on two businesses: innovative medicines and medical technology. The pharmaceutical arm develops treatments in immunology, oncology, neuroscience and infectious disease, while the medtech division sells surgical tools, orthopedic implants, heart devices and vision products. The consumer brands most people associate with the name were spun off into a separate company called Kenvue in 2023. Founded in 1886, J&J holds one of the strongest balance sheets in corporate America and a dividend record spanning more than half a century.